Stock analysts at Roth Capital lifted their price objective on shares of EnteroMedics (NASDAQ:ETRM) from $2.00 to $3.00 in a report issued on Wednesday, AnalystRatingsNetwork.com reports. Roth Capital’s target price would indicate a potential upside of 54.64% from the company’s current price. Shares of EnteroMedics (NASDAQ:ETRM) traded down 13.39% on Wednesday, hitting $1.94. 9,328,392 shares […]
EnteroMedics Price Target Raised to $3.00 at Roth Capital (ETRM) is a post from: Zolmax
The post EnteroMedics Price Target Raised to $3.00 at Roth Capital (ETRM) appeared first on Zolmax.
